Skip to main content
. 2024 Jan 10;14:1326078. doi: 10.3389/fimmu.2023.1326078

Figure 2.

Figure 2

Therapy timeline of individual patients. ICI, Immune checkpoint inhibitor treatment; AIH, Autoimmune hepatitis; PSC, primary sclerosing cholangitis; PBC, primary biliary cholangitis. Hepatic irAEs of grades I and II occurred. A flare of the underlying autoimmune disease could not be distinguished from an irAE.